News
After cancer, abortion experience highlights post-Roe reality
A 2021 study found the rate of maternal mortality was almost two times higher in states that restricted abortion access compared with those that...
News
$3 billion in cancer drug waste: Can it be salvaged?
Although most oncology drugs don’t incur substantial waste, even small volumes can translate to millions of dollars a year.
News
The evolving HER2+ metastatic breast cancer landscape: Novel agents and promising combination therapies
“The fact that we’re now talking about fourth- and fifth-line therapies for HER2-positive MBC represents a major advance in the management of...
News
Liquid biopsy in metastatic breast cancer management: Where does it stand in clinical practice?
Liquid biopsies — blood analyses that allow oncologists to detect circulating tumor cells and circulating tumor DNA in the blood — are...
News
Biomarker testing in metastatic breast cancer management: ‘Essential’
Defining a breast tumor can be tricky because these cancers often don’t fit neatly into predefined categories.
News
Key strategies for managing breast cancer brain metastases
Because our systemic therapies in breast cancer are...
News
Evolving strategies in sequencing for HER2+ MBC therapy
In a 12-month window, the FDA approved four agents targeting HER2-positive MBC.
News
How has COVID-19 affected metastatic breast cancer treatment decisions?
Patients with metastatic breast cancer (MBC) face an elevated risk of severe...